Top 10 articles for 2023 5 December 2023 Perhaps unsurprisingly the top stories during 2023 were related to the availability, or otherwise, of medications. The nationwide shortage of Ozempic hit the headlines at the start of 2023, and concerns still remain high for those struggling to access a regular supply. Several months later the potential withdrawal of Fiasp from the PBS understandingly sparked angst and distress in the community. These two issues were a major driving force behind the launch of our Spark Change platform. We have committed to fight for change on these issues, plus others. We urge you to add your voice on topics that concern you here. While Ozempic and Fiasp took out the top two spots for the most read articles on our website in 2023, the following eight articles were not far behind. Accessing your HbA1c results online through My Health Record Diabetes Australia welcomes cheaper, more convenient access to medicines Pain, numbness, burning? It could be peripheral neuropathy Recommended vaccinations for those living with type 2 diabetes Bionic pancreas approved by FDA Tube-free insulin pumps Pholcodine withdrawn: What you need to know about cough suppressants this winter Three commonly asked questions about exercise and diabetes
Blog 2 April 2024 Vale John Turtle AO Diabetes Australia joins with our unifying partners in extending our condolences to the family of Emeritus Professor John Turtle AO following his sad passing at the age of 87. Continue Reading
Media releases 14 March 2024 World Kidney Day focus on promising DARP research Australia may be on the cusp of a major advance in our understanding of diabetes-related kidney disease with new research by Monash's Dr Phillip Kantharidis. Continue Reading
Blog 8 March 2024 International Women’s Day 2024: Invest in Women. Accelerate Progress Diabetes Australia acknowledges and celebrates the pioneering women of both past and present through the theme of 'Invest in Women, Accelerate Progress'. Continue Reading